Showing results (51-60 of 85) with videos related to
Sort By:
Pageof 9
Cancer Chemotherapy and Pharmacology|January 1, 1988
Dose-dependent pharmacokinetics of flavone acetic acid in miceG Damia, M L Zanette, C Rossi, et al.Dental Cadmos|March 15, 1990
[Handicapped patients. General anesthesia or sedation?]G Bettelli, M P Giulietti, G Bitelli, et al.Cancer Research|March 31, 2001
4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548), a novel anticancer agent active against tumor cell lines with different resistance mechanismsS Marchini, G Damia, M Broggini, et al.Cancer Chemotherapy and Pharmacology|January 1, 1992
Activity of aphidicolin glycinate alone or in combination with cisplatin in a murine ovarian tumor resistant to cisplatinG Damia, G Tagliabue, M Zucchetti, et al.Carcinogenesis|March 1, 1994
3T3 NIH murine fibroblasts and B78 murine melanoma cells expressing the Escherichia coli N3-methyladenine-DNA glycosylase I do not become resistant to alkylating agentsL Imperatori, G Damia, P Taverna, et al.Blood|March 1, 1992
Administration of recombinant human interleukin-7 alters the frequency and number of myeloid progenitor cells in the bone marrow and spleen of miceG Damia, K L Komschlies, C R Faltynek, et al.Neoplasia (New York, N.Y.)|April 28, 2001
Cisplatinum and taxol induce different patterns of p53 phosphorylationG Damia, L Filiberti, F Vikhanskaya, et al.Critical Care Medicine|December 1, 1990
Influence of parenteral nutrition on leg nitrogen exchange in injured patientsG Iapichino, D Radrizzani, G Bonetti, et al.European Journal of Cancer (Oxford, England : 1990)|February 13, 2001
Ecteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of actionE Erba, D Bergamaschi, L Bassano, et al.European Journal of Cancer (Oxford, England : 1990)|February 5, 2008
Role of homologous recombination in trabectedin-induced DNA damageM Tavecchio, M Simone, E Erba, et al.Pageof 9